'Click' D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity

被引:38
作者
Zhang, Jing [2 ]
Zhang, Hai [1 ]
Cai, Wenxian [1 ]
Yu, Leiping [1 ]
Zhen, Xuechu [1 ]
Zhang, Ao [2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Neuropharmacol Lab, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, SOMCL, Shanghai 201203, Peoples R China
基金
美国国家科学基金会;
关键词
Arylbenzazepine; Arylpiperazine; Click reaction; Dopamine receptor; Serotonin 5-HT1A receptor; PARKINSONS-DISEASE; SEROTONIN; LIGANDS; COMPLICATIONS; DOPAMINE-D-2; THERAPEUTICS; DERIVATIVES; THERAPY;
D O I
10.1016/j.bmc.2009.06.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of new 1-aryl-3-benzazepine derivatives containing an arylpiperazinyl function as the N3 substituent were synthesized by combining a D-1 receptor agonistic pharmacophore and a 5-HT1A receptor pharmacophore through Click reaction. Interestingly, these compounds generally do not have good binding affinity at the D-1 receptor, but most compounds are potent at both D-2 and 5-HT1A receptors. Compound 8h, containing 1-m-tolyl-benzazepine scaffold and 2-methoxyphenylpiperazine core, displayed good affinity at all tested receptors, with K-i values of 144, 80, and 133 nM, for the D-1, D-2, and 5-HT1A receptors, respectively. Compound 13 with the triazole moiety formed differently from that in 8h showed the highest affinity at the D-2 receptor with K-i value of 19 nM. This compound also showed moderate affinity at the 5-HT1A (K-i, 105 nM), and D-1 (K-i, 551 nM) receptors. Functional assays indicated that both compounds 13 and 8h are antagonists at D-1 and D-2 receptors, whereas full agonistic activity at the 5-HT1A receptor was observed. In agreement with the binding affinity, compound 13 is a high efficacy D-2 antagonist and 5-HT1A agonist. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4873 / 4880
页数:8
相关论文
共 50 条
  • [21] Pharmacological analysis of human D1 and D2 dopamine receptor missense variants
    Al-Fulaij, Munya A.
    Ren, Yong
    Beinborn, Martin
    Kopin, Alan S.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 34 (03) : 211 - 223
  • [22] Effects of Dopamine D1 and D2 Receptor Antagonists on Laryngeal Neurophysiology in the Rat
    Feng, Xin
    Henriquez, Victor M.
    Walters, Judith R.
    Ludlow, Christy L.
    JOURNAL OF NEUROPHYSIOLOGY, 2009, 102 (02) : 1193 - 1205
  • [23] Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations
    Ringel, Lauren E.
    Basken, Jaime N.
    Grant, Laura M.
    Ciucci, Michelle R.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 252 : 252 - 259
  • [24] Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands
    Weber, Karen C.
    Salum, Livia B.
    Honorio, Kathia M.
    Andricopulo, Adriano D.
    da Silva, Alberico B. F.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (04) : 1508 - 1514
  • [25] Classification of 5-HT1A receptor agonists and antagonists using GA-SVM method
    Zhu, Xue-lian
    Cai, Hai-yan
    Xu, Zhi-jian
    Wang, Yong
    Wang, He-yao
    Zhang, Ao
    Zhu, Wei-liang
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (11) : 1424 - 1430
  • [26] Distribution of D1 and D2 receptor- immunoreactive neurons in the paraventricular nucleus of the hypothalamus in the rat
    Ran, Xuerui
    Yang, Yanli
    Meng, Yamei
    Li, Yong
    Zhou, Li
    Wang, Zhiyong
    Zhu, Jinxia
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 98 : 97 - 103
  • [27] Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications
    A. R. Braun
    M. Laruelle
    M. M. Mouradian
    Journal of Neural Transmission, 1997, 104 : 341 - 362
  • [28] Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells
    Sakolsky, DJ
    Ashby, B
    MOLECULAR BRAIN RESEARCH, 2000, 84 (1-2): : 158 - 161
  • [29] The impact of the halogen bonding on D2 and 5-HT1A/5-HT7 receptor activity of azinesulfonamides of 4-[(2-ethyl)piperidinyl-1-yl] phenylpiperazines with antipsychotic and antidepressant properties
    Partyka, Anna
    Kurczab, Rafal
    Canale, Vittorio
    Satala, Grzegorz
    Marciniec, Krzysztof
    Pasierb, Agnieszka
    Jastrzebska-Wiesek, Magdalena
    Pawlowski, Maciej
    Wesolowska, Anna
    Bojarski, Andrzej J.
    Zajdel, Pawel
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (14) : 3638 - 3648
  • [30] Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease
    Lindenbach, David
    Dupre, Kristin B.
    Jaunarajs, Karen L. Eskow
    Ostock, Corinne Y.
    Goldenberg, Adam A.
    Bishop, Christopher
    BRAIN RESEARCH, 2013, 1537 : 327 - 339